We considered this elevation of AST and ALT as hepatotoxicity caused by gefitinib, because no other reasons, for example, viral hepatitis and alcoholic liver injury were found and discontinuation of gefitinib retrieved the levels of AST and ALT in all patients. Here, GPT is linked to animal viral hepatitis.